About Inso Biosciences

Inso Biosciences develops microfluidic hardware platforms for high-efficiency genomic sample handling, focusing on long-read DNA extraction and multiomic sample processing. Their technology addresses the challenges of cellular material processing and pathogen surveillance, enhancing accuracy and speed in genomic research.

```xml <problem> Traditional DNA extraction methods often rely on affinity binding, which can lead to DNA degradation, size limitations, and difficulties in multiomic sample processing. These methods can be slow, require extensive sample handling, and may not be suitable for low-input samples. </problem> <solution> Inso Biosciences offers a microfluidic platform for automated, high-efficiency DNA extraction and purification, designed to overcome the limitations of conventional methods. Their patented micropillar technology physically captures DNA, avoiding the use of affinity binding and minimizing degradation. The system enables rapid extraction of high molecular weight (HMW) DNA, multiomic isolations, and removal of metagenomic contaminants. The benchtop system simplifies the workflow, reduces sample handling, and is compatible with various sample types, including blood and cell lines, preparing high-quality DNA for any sequencer. </solution> <features> - Microfluidic cartridge with micropillar technology for physical DNA capture - Automated on-chip lysis, extraction, and purification in a single step - Rapid DNA extraction in 15 minutes, or 45 minutes for HMW DNA - Compatible with cell lines and blood samples - Multiomic DNA + RNA isolation capabilities - Size-based separation for removal of metagenomic contaminants - Average HMW DNA molecule lengths of 50 kb to 1,000+ kb - Automatable workflow with minimal reagents and waste </features> <target_audience> The primary target audience includes genomics researchers, molecular biologists, and clinical scientists who require efficient and reliable DNA extraction for sequencing and multiomic analysis. </target_audience> ```

What does Inso Biosciences do?

Where is Inso Biosciences located?

Inso Biosciences is based in East New York, United States.

When was Inso Biosciences founded?

Inso Biosciences was founded in 2020.

How much funding has Inso Biosciences raised?

Inso Biosciences has raised 3530000.

Location

East New York, United States

Founded

2020

Funding

3530000

Employees

4 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Inso Biosciences

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

inso.bio 500+

Crunchbase

Founded 2020 – East New York, United States

Funding

Estimated Funding

$3M+

Team (<5)

No team information available.

Company Description

Problem

Traditional DNA extraction methods often rely on affinity binding, which can lead to DNA degradation, size limitations, and difficulties in multiomic sample processing. These methods can be slow, require extensive sample handling, and may not be suitable for low-input samples.

Solution

Inso Biosciences offers a microfluidic platform for automated, high-efficiency DNA extraction and purification, designed to overcome the limitations of conventional methods. Their patented micropillar technology physically captures DNA, avoiding the use of affinity binding and minimizing degradation. The system enables rapid extraction of high molecular weight (HMW) DNA, multiomic isolations, and removal of metagenomic contaminants. The benchtop system simplifies the workflow, reduces sample handling, and is compatible with various sample types, including blood and cell lines, preparing high-quality DNA for any sequencer.

Features

Microfluidic cartridge with micropillar technology for physical DNA capture

Automated on-chip lysis, extraction, and purification in a single step

Rapid DNA extraction in 15 minutes, or 45 minutes for HMW DNA

Compatible with cell lines and blood samples

Multiomic DNA + RNA isolation capabilities

Size-based separation for removal of metagenomic contaminants

Average HMW DNA molecule lengths of 50 kb to 1,000+ kb

Automatable workflow with minimal reagents and waste

Target Audience

The primary target audience includes genomics researchers, molecular biologists, and clinical scientists who require efficient and reliable DNA extraction for sequencing and multiomic analysis.